Financhill
Buy
71

CMI Quote, Financials, Valuation and Earnings

Last price:
$593.19
Seasonality move :
5.24%
Day range:
$588.58 - $602.44
52-week range:
$260.02 - $617.98
Dividend yield:
1.32%
P/E ratio:
28.92x
P/S ratio:
2.44x
P/B ratio:
6.64x
Volume:
935.5K
Avg. volume:
1M
1-year change:
54.34%
Market cap:
$82B
Revenue:
$33.7B
EPS (TTM):
$20.51
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $24B $28.1B $34B $34.1B $33.7B
Revenue Growth (YoY) 21.25% 16.87% 21.28% 0.16% -1.27%
 
Cost of Revenues $18.3B $21.4B $25.9B $25.8B $25.3B
Gross Profit $5.7B $6.6B $8.1B $8.3B $8.4B
Gross Profit Margin 23.62% 23.68% 23.79% 24.36% 24.99%
 
R&D Expenses $1.1B $1.3B $1.5B $1.5B $1.4B
Selling, General & Admin $2.4B $2.7B $3.3B $3.3B $3.1B
Other Inc / (Exp) $580M $313M -$1.6B $1.7B --
Operating Expenses $3.5B $4B $4.8B $4.7B $4.5B
Operating Income $2.2B $2.7B $3.3B $3.6B $3.9B
 
Net Interest Expenses $111M $199M $375M $370M $329M
EBT. Incl. Unusual Items $2.8B $2.8B $1.6B $4.9B $4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $587M $636M $786M $835M $1B
Net Income to Company $2.2B $2.2B $840M $4.1B $3B
 
Minority Interest in Earnings $33M $32M $105M $122M $114M
Net Income to Common Excl Extra Items $2.2B $2.2B $840M $4.1B $3B
 
Basic EPS (Cont. Ops) $14.74 $15.20 $5.19 $28.55 $20.62
Diluted EPS (Cont. Ops) $14.61 $15.12 $5.15 $28.37 $20.50
Weighted Average Basic Share $144.6M $141.5M $141.7M $138.2M $137.9M
Weighted Average Diluted Share $145.9M $142.3M $142.7M $139.1M $138.7M
 
EBITDA $2.9B $3.5B $4.3B $4.6B $5B
EBIT $2.2B $2.7B $3.3B $3.6B $3.9B
 
Revenue (Reported) $24B $28.1B $34B $34.1B $33.7B
Operating Income (Reported) $2.2B $2.7B $3.3B $3.6B $3.9B
Operating Income (Adjusted) $2.2B $2.7B $3.3B $3.6B $3.9B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $5.9B $7.8B $8.5B $8.4B $8.5B
Revenue Growth (YoY) 0.34% 32.82% 9.82% -1.01% 1.05%
 
Cost of Revenues $4.5B $6B $6.6B $6.4B $6.6B
Gross Profit $1.3B $1.8B $2B $2B $2B
Gross Profit Margin 22.43% 23.01% 22.97% 23.7% 22.86%
 
R&D Expenses $288M $333M $390M $356M $350M
Selling, General & Admin $629M $742M $876M $801M $786M
Other Inc / (Exp) $148M $195M -$1.9B $53M --
Operating Expenses $917M $1.1B $1.3B $1.2B $1.1B
Operating Income $395M $713M $694M $845M $815M
 
Net Interest Expenses $26M $87M $92M $89M $82M
EBT. Incl. Unusual Items $514M $778M -$1.2B $662M $791M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $114M $134M $163M $217M $171M
Net Income to Company $400M $644M -$1.4B $445M $620M
 
Minority Interest in Earnings $6M $13M $38M $27M $27M
Net Income to Common Excl Extra Items $400M $644M -$1.4B $445M $620M
 
Basic EPS (Cont. Ops) $2.76 $4.47 -$10.08 $3.04 $4.29
Diluted EPS (Cont. Ops) $2.73 $4.43 -$10.08 $3.02 $4.27
Weighted Average Basic Share $142.9M $141.3M $141.9M $137.4M $138.2M
Weighted Average Diluted Share $144.1M $142.3M $141.9M $138.4M $139M
 
EBITDA $563M $953M $954M $1.1B $1.1B
EBIT $395M $713M $694M $845M $815M
 
Revenue (Reported) $5.9B $7.8B $8.5B $8.4B $8.5B
Operating Income (Reported) $395M $713M $694M $845M $815M
Operating Income (Adjusted) $395M $713M $694M $845M $815M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Revenue $24B $28.1B $34.1B $34.1B $33.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $18.3B $21.4B $25.9B $25.8B $25.3B
Gross Profit $5.7B $6.6B $8.1B $8.3B $8.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.1B $1.3B $1.5B $1.5B $1.4B
Selling, General & Admin $2.4B $2.7B $3.3B $3.3B $3.1B
Other Inc / (Exp) $580M $392M -$1.6B $1.7B --
Operating Expenses $3.5B $4B $4.8B $4.7B $4.5B
Operating Income $2.2B $2.7B $3.3B $3.6B $3.9B
 
Net Interest Expenses $114M $199M $375M $370M $329M
EBT. Incl. Unusual Items $2.8B $2.8B $1.6B $4.9B $4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $587M $636M $786M $835M $1B
Net Income to Company $2.2B $2.2B $840M $4.1B $3B
 
Minority Interest in Earnings $33M $32M $105M $122M $114M
Net Income to Common Excl Extra Items $2.2B $2.2B $840M $4.1B $3B
 
Basic EPS (Cont. Ops) $14.72 $15.21 $5.21 $28.34 $20.62
Diluted EPS (Cont. Ops) $14.59 $15.12 $5.11 $28.17 $20.51
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $2.9B $3.5B $4.3B $4.6B $5B
EBIT $2.2B $2.7B $3.3B $3.6B $3.9B
 
Revenue (Reported) $24B $28.1B $34.1B $34.1B $33.7B
Operating Income (Reported) $2.2B $2.7B $3.3B $3.6B $3.9B
Operating Income (Adjusted) $2.2B $2.7B $3.3B $3.6B $3.9B
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Revenue $28.1B $34.1B $34.1B $33.7B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $21.4B $25.9B $25.8B $25.3B --
Gross Profit $6.6B $8.1B $8.3B $8.4B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.3B $1.5B $1.5B $1.4B --
Selling, General & Admin $2.7B $3.3B $3.3B $3.1B --
Other Inc / (Exp) $392M -$1.6B $1.7B $266M --
Operating Expenses $4B $4.8B $4.7B $4.5B --
Operating Income $2.7B $3.3B $3.6B $3.9B --
 
Net Interest Expenses $199M $375M $370M $329M --
EBT. Incl. Unusual Items $2.8B $1.6B $4.9B $4B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $636M $786M $835M $1B --
Net Income to Company $2.2B $840M $4.1B $3B --
 
Minority Interest in Earnings $32M $105M $122M $114M --
Net Income to Common Excl Extra Items $2.2B $840M $4.1B $3B --
 
Basic EPS (Cont. Ops) $15.21 $5.21 $28.34 $20.62 --
Diluted EPS (Cont. Ops) $15.12 $5.11 $28.17 $20.51 --
Weighted Average Basic Share $565.8M $566.9M $553M $551.6M --
Weighted Average Diluted Share $569.4M $569.6M $556.5M $554.6M --
 
EBITDA $3.5B $4.3B $4.6B $5B --
EBIT $2.7B $3.3B $3.6B $3.9B --
 
Revenue (Reported) $28.1B $34.1B $34.1B $33.7B --
Operating Income (Reported) $2.7B $3.3B $3.6B $3.9B --
Operating Income (Adjusted) $2.7B $3.3B $3.6B $3.9B --
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $3.2B $2.6B $2.7B $2.3B $3.6B
Short Term Investments $595M $472M $562M $593M --
Accounts Receivable, Net $4B $5.2B $5.6B $5.2B $5.8B
Inventory $4.4B $5.6B $5.7B $5.7B $5.8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $777M $1.1B $1.2B $1.6B --
Total Current Assets $12.3B $14.5B $15.2B $14.8B $16.9B
 
Property Plant And Equipment $4.9B $6B $6.8B $6.9B $7.5B
Long-Term Investments $1.5B $1.8B $1.8B $1.9B $2.2B
Goodwill $1.3B $2.3B $2.5B $2.4B --
Other Intangibles $900M $2.7B $2.5B $2.4B --
Other Long-Term Assets $894M $1B $960M $982M --
Total Assets $23.7B $30.3B $32B $31.5B $34B
 
Accounts Payable $3B $4.3B $4.3B $4B $3.8B
Accrued Expenses $1.5B $1.7B $3.7B $2B --
Current Portion Of Long-Term Debt $59M $783M $118M $660M --
Current Portion Of Capital Lease Obligations $128M $132M $138M $130M --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $7.1B $11.4B $12.9B $11.2B $9.6B
 
Long-Term Debt $3.9B $4.9B $5.2B $5.2B $7.2B
Capital Leases -- -- -- -- --
Total Liabilities $14.3B $20.1B $22.1B $20.2B $20.6B
 
Common Stock $2.4B $2.2B $2.6B $2.6B $2.7B
Other Common Equity Adj -- -$1.9B -$2.2B -$2.4B --
Common Equity $8.5B $9B $8.9B $10.3B $12.3B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $927M $1.3B $1.1B $1B $1.1B
Total Equity $9.4B $10.2B $9.9B $11.3B $13.4B
 
Total Liabilities and Equity $23.7B $30.3B $32B $31.5B $34B
Cash and Short Terms $3.2B $2.6B $2.7B $2.3B $3.6B
Total Debt $4B $5.4B $5.3B $5.9B $7.3B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Cash and Equivalents $3.2B $2.6B $2.7B $2.3B $3.6B
Short Term Investments $595M $472M $562M $593M --
Accounts Receivable, Net $4B $5.2B $5.6B $5.2B $5.8B
Inventory $4.4B $5.6B $5.7B $5.7B $5.8B
Prepaid Expenses -- -- -- -- --
Other Current Assets $777M $1.1B $1.2B $1.6B --
Total Current Assets $12.3B $14.5B $15.2B $14.8B $16.9B
 
Property Plant And Equipment $4.9B $6B $6.8B $6.9B $7.5B
Long-Term Investments $1.5B $1.8B $1.8B $1.9B $2.2B
Goodwill $1.3B $2.3B $2.5B $2.4B --
Other Intangibles $900M $2.7B $2.5B $2.4B --
Other Long-Term Assets $894M $1B $960M $982M --
Total Assets $23.7B $30.3B $32B $31.5B $34B
 
Accounts Payable $3B $4.3B $4.3B $4B $3.8B
Accrued Expenses $1.5B $1.7B $3.7B $2B --
Current Portion Of Long-Term Debt $59M $783M $118M $660M --
Current Portion Of Capital Lease Obligations $128M $132M $138M $130M --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $7.1B $11.4B $12.9B $11.2B $9.6B
 
Long-Term Debt $3.9B $4.9B $5.2B $5.2B $7.2B
Capital Leases -- -- -- -- --
Total Liabilities $14.3B $20.1B $22.1B $20.2B $20.6B
 
Common Stock $2.4B $2.2B $2.6B $2.6B $2.7B
Other Common Equity Adj -- -$1.9B -$2.2B -$2.4B --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $927M $1.3B $1.1B $1B $1.1B
Total Equity $9.4B $10.2B $9.9B $11.3B $13.4B
 
Total Liabilities and Equity $23.7B $30.3B $32B $31.5B $34B
Cash and Short Terms $3.2B $2.6B $2.7B $2.3B $3.6B
Total Debt $4B $5.4B $5.3B $5.9B $7.3B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $2.2B $2.2B $840M $4.1B $3B
Depreciation & Amoritzation $659M $781M $1B $1.1B $1.1B
Stock-Based Compensation $37M -- -- -- --
Change in Accounts Receivable -$174M -$697M -$330M $298M -$612M
Change in Inventories -$945M -$567M -- -$402M -$39M
Cash From Operations $2.3B $2B $4B $1.5B $3.6B
 
Capital Expenditures $786M $916M $1.2B $1.2B $1.2B
Cash Acquisitions -- $3.2B $467M $282M $122M
Cash From Investing -$873M -$4.2B -$1.8B -$1.8B -$1.8B
 
Dividends Paid (Ex Special Dividend) $809M $855M $921M $969M $1.1B
Special Dividend Paid
Long-Term Debt Issued $79M $2.1B $861M $2.7B --
Long-Term Debt Repaid -$73M -$1.6B -$1.1B -$1.6B --
Repurchase of Common Stock $1.4B $374M -- -- --
Other Financing Activities -$12M $84M -$202M -$119M --
Cash From Financing -$2.2B $1.7B -$2B -$123M -$662M
 
Beginning Cash (CF) $2.6B $2.1B $2.2B $1.7B $2.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$809M -$491M $78M -$508M $1.2B
Ending Cash (CF) $1.8B $1.7B $2.2B $1.1B $4.1B
 
Levered Free Cash Flow $1.5B $1B $2.8B $279M $2.4B
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $400M $644M -$1.4B $445M $620M
Depreciation & Amoritzation $165M $240M $260M $269M $278M
Stock-Based Compensation $12M -- -- -- --
Change in Accounts Receivable $179M -$364M $117M $189M -$146M
Change in Inventories -$26M $30M $318M $324M $407M
Cash From Operations $732M $817M $1.5B $1.4B $1.5B
 
Capital Expenditures $388M $419M $519M $540M $544M
Cash Acquisitions -- $183M $340M $224M $110M
Cash From Investing -$595M -$676M -$958M -$763M -$995M
 
Dividends Paid (Ex Special Dividend) $208M $222M $238M $250M $277M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $44M $27M $82M $97M --
Long-Term Debt Repaid -$16M -$480M -$745M -$182M --
Repurchase of Common Stock $174M $4M -- -- --
Other Financing Activities $27M $56M $6M -$25M --
Cash From Financing -$148M -$442M -$933M -$687M -$259M
 
Beginning Cash (CF) $2.6B $2.1B $2.2B $1.7B $2.8B
Foreign Exchange Rate Adjustment $15M -$97M -$1M -$34M -$1M
Additions / Reductions $4M -$398M -$433M -$62M $279M
Ending Cash (CF) $2.6B $1.6B $1.7B $1.6B $3.1B
 
Levered Free Cash Flow $344M $398M $940M $882M $990M
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Net Income to Stockholders $2.2B $2.2B $840M $4.1B $3B
Depreciation & Amoritzation $659M $781M $1B $1.1B $1.1B
Stock-Based Compensation $37M -- -- -- --
Change in Accounts Receivable -$174M -$697M -$330M $298M -$612M
Change in Inventories -$945M -$567M -- -$402M -$39M
Cash From Operations $2.3B $2B $4B $1.5B $3.6B
 
Capital Expenditures $786M $916M $1.2B $1.2B $1.2B
Cash Acquisitions -- $3.2B $467M $282M $122M
Cash From Investing -$873M -$4.2B -$1.8B -$1.8B -$1.8B
 
Dividends Paid (Ex Special Dividend) $809M $855M $921M $969M $1.1B
Special Dividend Paid
Long-Term Debt Issued -- $2.1B $861M $2.7B --
Long-Term Debt Repaid -$73M -$1.6B -$1.1B -$1.6B --
Repurchase of Common Stock $1.4B $374M -- -- --
Other Financing Activities -$12M $84M -$202M -$119M --
Cash From Financing -$2.2B $1.7B -$2B -$123M -$662M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$809M -$491M $78M -$508M $1.2B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1.5B $1B $2.8B $279M $2.4B
Period Ending 2022-12-31 2023-12-31 2024-12-31 2025-12-31 2026-12-31
Net Income to Stockholders $2.2B $840M $4.1B $3B --
Depreciation & Amoritzation $781M $1B $1.1B $1.1B --
Stock-Based Compensation $24M -- -- -- --
Change in Accounts Receivable -$697M -$330M $298M -$612M --
Change in Inventories -$567M -- -$402M -$39M --
Cash From Operations $2B $4B $1.5B $3.6B --
 
Capital Expenditures $916M $1.2B $1.2B $1.2B --
Cash Acquisitions $3.2B $467M $282M $122M --
Cash From Investing -$4.2B -$1.8B -$1.8B -$1.8B --
 
Dividends Paid (Ex Special Dividend) $855M $921M $969M $1.1B --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $2.1B $861M $2.7B $2.1B --
Long-Term Debt Repaid -$1.6B -$1.1B -$1.6B -$210M --
Repurchase of Common Stock $374M -- -- -- --
Other Financing Activities $84M -$202M -$119M -$104M --
Cash From Financing $1.7B -$2B -$123M -$662M --
 
Beginning Cash (CF) $9.3B $8.6B $7.5B $9.3B --
Foreign Exchange Rate Adjustment $50M -$68M -$40M $56M --
Additions / Reductions -$491M $78M -$508M $1.2B --
Ending Cash (CF) $8.9B $8.6B $7B $10.5B --
 
Levered Free Cash Flow $1B $2.8B $279M $2.4B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock